Hutch News
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Dr. Cameron Turtle receives Anderson Family Endowed Chair for Immunotherapy
Gift will ‘help new ideas move rapidly toward the patients who need them’
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Immunotherapy trailblazer Dr. Phil Greenberg to receive E. Donnall Thomas Lecture and Prize
American Society of Hematology honors his ‘vision, creativity and scientific rigor’ in T-cell therapy research
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists
He is among 52 immunologists selected for the AAI 2019 inaugural class of fellows, including 5 Nobel laureates
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Dr. Robert Hickman, inventor of Hickman catheter, dies at age 92
Lifesaving device was ‘a gift to the world,’ former colleagues say
Drs. Fred Appelbaum and Phil Greenberg elected to AACR Academy
They are among 22 scientists from around the world to join the 2019 class of Fellows
Seattle mayor and melanoma survivor Jenny Durkan visits Fred Hutch
Mayor shares personal story as Hutch scientists outline the future of cancer therapy
Dr. Tijana Martinov named a 2019 Parker Scholar
Early-career scientist will use funding for immunotherapy research in multiple myeloma
On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma
How a phone call helped shape the field of bone marrow transplant
A lifesaving new leukemia treatment was harming some patients’ digestive organs, and no one really understood why. So, over 40 years, Dr. George McDonald helped fill in the gaps.
.jpg)
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Dr. Kristin Anderson receives research grant from Ovarian Cancer Research Alliance
Anderson will use funds to expand research in boosting anti-tumor immune responses